Background: It is estimated that immunization averts between 2 and 3 million deaths every year. India has declared 2012-2013 as a year of intensi ication of routine immunization. Because the doctors train the health workers and paramedics in proper implementation of vaccine delivery, their knowledge should be perfect and no error or ambiguity of any sort is pardonable. Research Question: What is the operational knowledge about immunization among doctors? What is the effect of training in routine immunization among doctors? What is the effect of supportive supervision on ield staff? Setting: Directorate of Health Services, Bangalore on 06/03/2007, East Godavari on 11/03/2007, Bangalore Mahanagar Pallike on 5-7/10/2007 and Mandya on 8-10/03/11. Supervision sessions were conducted at 33 sites of the Dakshina Kannada district. Study Design: This study is cross-sectional. Participants: Participants include RCH of icers, medical of icers, and immunization ield staff. Materials and Methods: The questionnaire and interview method was followed. The pretest questionnaire was administered to RCH of icers and MOs. The training program in two of these four areas was held immediately and the impact of training through the posttest was studied in one area. Supportive supervision sessions were then conducted in purposively selected immunization sites. Results: The overall knowledge among doctors improved after the training session. The mean score improved signi icantly in all the variables included in the study. Supportive supervision was also found useful in improving the routine immunization sessions at the ield level.
Immunization is one of the most cost effective public health interventions; eradicated small pox in the past and now polio has been stopped in all countries except for 2: Afghanistan and Pakistan. It averts an estimated 3 million deaths annually. Despite the success, globally, in 2015 an estimated 19.4 million infants did not receive even basic routine immunization services and yearly ~1.5 million children die of VPD. 1 Since the inception of EPI in 1978, India is consistently trying to raise and sustain the coverage ≥90% with 6 basic vaccines passing through UIP in 1985, CSSM in 1992, part of RCH in 1997 / NRHM in 2005, introduction of Measles 2 nd dose in 2010. 2 Coverage is not uniform ABSTRACT Background: Since the inception of EPI in 1978, India is consistently trying to achieve and sustain high vaccination coverage. The objectives were to detect population immunity gap in the catchment area of RHTC through the offline tool-immunogram and to evolve the shortest period required for closing this gap using immunogram and supportive supervision. Methods: A short term interventional field study from December 2012 to April 2013 done in RHTC of KVG Medical College. Children born since 1 st April 2010 were line-listed chronologically in the "immunogram" which can both record vaccination data and measure programme indicatorshence the name. Data analyzed and baseline indicators obtained. Sustained Supportive Supervision provided was documented at the RHTC. The study ended on 31st March 2013 on clearance of the backlog coinciding with the launch of pentavalent-replacing DPT + HepB from 1 st April 2013 in Karnataka. Results: RHTC is a good performing planning unit with high baseline coverage; ~90% for primary vaccination. Significant impact was seen with measles 1, DPT/OPV booster dose and Measles 2nd dose which increased from 89 to 97%, 85 to 95% and 55 to 94% respectively in consecutive intensified regular sessions in 3 months. Conclusions: Immunogram precisely detected the immunity gap in a good performing planning unit and rapidly closed the gap in just 3 months, realizing the theme of WHO world immunization week 2016close the immunization gap. The planning unit graduated from good to better forever.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.